IntelliPharmaCeutics (QB) Stock Price

0.00495 (3.14%)
Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Canna Trader Pro
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
IntelliPharmaCeutics International Inc (QB) IPCIF OTCMarkets Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00495 3.14% 0.1624 16:00:06
Open Price Low Price High Price Close Price Prev Close
0.16 0.15 0.1624 0.1624 0.15745
Bid Price Ask Price Spread News
0.144 0.173 0.029 - -
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
12 103,801 $ 0.159265 $ 16,532 - 0.058 - 0.7099
Last Trade Time Type Quantity Stock Price Currency
14:04:21 1 $ 0.155 USD

IntelliPharmaCeutics (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 3.77M 23.20M - $ - $ - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
6.21k $ - 0.00% - -

more financials information »

IntelliPharmaCeutics (QB) News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IPCIF Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.160.17460.140.160413682,0780.00241.5%
1 Month0.1360.17460.110.151607970,5510.026419.41%
3 Months0.17680.18810.110.148005641,601-0.0144-8.14%
6 Months0.14970.2622180.05880.147353338,2530.01278.48%
1 Year0.640.70990.0580.18618265,733-0.4776-74.63%
3 Years0.16561.500.0580.3345186114,590-0.0032-1.93%
5 Years0.16561.500.0580.3345186114,590-0.0032-1.93%

IntelliPharmaCeutics (QB) Description

Intellipharmaceutics International Inc. is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. The Company's patented Hypermatrix technology is a multidimensional controlled-release drug delivery platform that can be applied to a wide range of existing and new pharmaceuticals. Intellipharmaceutics has developed several drug delivery systems based on this technology platform, with a pipeline of products (some of which have received FDA approval) in various stages of development. The Company has ANDA and NDA 505(b)(2) drug product candidates in its development pipeline. These include the Company's abuse-deterrent oxycodone hydrochloride extended release formulation ("Oxycodone ER") based on its proprietary nPODDDS novel Point Of Divergence Drug Delivery System (for which an NDA has been filed with the FDA), and Regabatin XR (pregabalin extended-release capsules).

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.